Renal Rehabilitation Among Patients With Kidney Failure

January 13, 2026 updated by: Merna Mabrouk Labib keriakous, Cairo University

Barriers to Renal Rehabilitation Among Patients With Kidney Failure in Governmental Hospitals in Cairo: A Cross-Sectional Study

The primary purpose of this study is to identify and analyze the barriers to renal rehabilitation among patients diagnosed with kidney failure in Cairo

Study Overview

Status

Completed

Conditions

Detailed Description

This study is a cross-sectional design aimed at identifying the barriers to renal rehabilitation among patients diagnosed with kidney failure in governemtnal hospitals in Cairo.

The sample size for this study was determined using G*POWER statistical software (version 3.1.9.2; Franz Faul, Universitat Kiel, Germany) and was based on a previous study by (Bossola et al., 2014). which reported a prevalence of 38.1%. The required sample size calculated for this study is N=155, with calculations made using a significance level (α) of 0.05 and a statistical power of 80%. This sample size is deemed appropriate for achieving the study's objectives and ensuring statistically significant results.

155 patients suffering from kidney failure will participate in the study. They will be selected randomly from the different governmental hospitals centers in Cairo, Informed consent Freely and voluntarily consent to participate in this research study (Effect of pelvic floor down-training exercise on females with idiopathic overactive bladder) under the supervision and direction of the researcher/ Merna Mabrouk A thorough description of the study procedures has been explained to me, and I understand that I may withdraw my consent and discontinue participation in this study research at any time without prejudice to me.

Study Type

Observational

Enrollment (Actual)

158

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Giza Governorate
      • Giza, Giza Governorate, Egypt, 3387722
        • Faculty of Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

  • Participants must have a confirmed diagnosis of kidney failure,
  • Participants must be 18 years of age or older
  • Participants must be willing and able to provide written informed consent (Appendix I).
  • Participants must be receiving treatment at one of the nephrology clinics in Cairo that are involved in the study.

Severe Cognitive Impairment or Psychiatric Disorders

  • Recent Participation in Similar Studies
  • Acute Medical Condition
  • Inability to Communicate
  • Pregnancy
  • Non-residency in Cairo
  • Non-compliance with Treatment

Description

Inclusion Criteria:

Participants must have a confirmed diagnosis of kidney failure,

  • Participants must be 18 years of age or older
  • Participants must be willing and able to provide written informed consent (Appendix I).
  • Participants must be receiving treatment at one of the nephrology clinics in Cairo that are involved in the study.

Exclusion Criteria:

Severe Cognitive Impairment or Psychiatric Disorders

  • Recent Participation in Similar Studies
  • Acute Medical Condition
  • Inability to Communicate
  • Pregnancy
  • Non-residency in Cairo
  • Non-compliance with Treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
Patients with kidney failure doing dialysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dialysis patients' perception regarding exercise benefits and barriers Questionnaire (DPEBBS)
Time Frame: 20 minutes
The perception of dialysis patients regarding exercise benefits and barriers will be measured using the DPEBBS
20 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 17, 2024

Primary Completion (Actual)

January 30, 2025

Study Completion (Actual)

January 30, 2025

Study Registration Dates

First Submitted

January 13, 2026

First Submitted That Met QC Criteria

January 13, 2026

First Posted (Actual)

January 21, 2026

Study Record Updates

Last Update Posted (Actual)

January 21, 2026

Last Update Submitted That Met QC Criteria

January 13, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Under request from Cairo Unive

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Failure Acute Chronic

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe